Q-Bank Breakdown: Familial dyslipidemias — Why Every Answer Choice Matters

Tag: Biochemistry > Lipid Metabolism

Familial dyslipidemias are classic USMLE territory because they force you to connect lipoprotein physiology (what carries what) to clinical outcomes (pancreatitis vs premature atherosclerosis) and lab patterns (TG vs LDL vs chylomicrons). The trick in many questions isn’t just knowing the right diagnosis—it’s knowing why every other option is wrong.

---

Clinical Vignette (Q-Bank Style)

A 14-year-old boy is brought to clinic for evaluation of recurrent abdominal pain. He has had two hospitalizations for acute pancreatitis. Physical exam shows multiple small yellow papules on his extensor surfaces. His blood sample appears milky after refrigeration. Lipid panel reveals markedly elevated triglycerides with normal total cholesterol.

Which underlying abnormality most likely explains this patient’s condition?

A. Defective LDL receptor
B. Apolipoprotein C-II deficiency
C. Apolipoprotein E mutation
D. Increased hepatic VLDL production due to insulin resistance
E. Defective ATP-binding cassette transporter (ABCA1)

---

Step-by-Step: What the vignette is telling you

Key clues:

• Recurrent pancreatitis + very high triglycerides → think chylomicronemia
• Eruptive xanthomas (small yellow papules on extensor surfaces) → very high TG
• Milky plasma after refrigeration (creamy supernatant) → chylomicrons
• Normal total cholesterol (often) → favors chylomicron problems over LDL problems

This constellation screams: Familial hyperchylomicronemia (Type I).

---

✅ Correct Answer: B. Apolipoprotein C-II deficiency

Why this is correct

ApoC-II is the essential cofactor that activates lipoprotein lipase (LPL) on endothelial surfaces. Without ApoC-II, LPL can’t effectively hydrolyze triglycerides in:

• Chylomicrons (dietary TG)
• VLDL (endogenous TG)

Result: severely elevated TG, chylomicron accumulation, and high risk of acute pancreatitis.

High-yield associations (Type I hyperchylomicronemia)

• Cause: LPL deficiency or ApoC-II deficiency
• Labs: ↑↑↑ TG, ↑ chylomicrons (± ↑ VLDL), often normal/near-normal LDL
• Clinical:
  • Recurrent pancreatitis (big USMLE clue)
  • Eruptive xanthomas
  • Lipemia retinalis
  • Hepatosplenomegaly
• Atherosclerosis risk: typically not increased (chylomicrons are too large to enter arterial intima easily)
• Treatment: very low-fat diet, avoid alcohol; medium-chain triglycerides can be helpful (absorbed directly via portal system, not packaged into chylomicrons)

---

Why Each Distractor Is Wrong (and what it would look like)

A. Defective LDL receptor → Familial hypercholesterolemia (Type IIa)

Why it’s wrong here: This vignette is dominated by triglycerides + chylomicrons + pancreatitis, not LDL.

What you’d expect instead:

• Labs: ↑↑ LDL (high total cholesterol), normal TG
• Clinical:
  • Tendon xanthomas (Achilles), xanthelasma
  • Premature atherosclerosis / MI
• High-yield: Autosomal dominant; also associated with ApoB-100 defects (impaired LDL binding)

Step tip: Tendon xanthomas = think LDL problems.
Pancreatitis = think TG/chylomicrons.

---

C. Apolipoprotein E mutation → Dysbetalipoproteinemia (Type III)

Why it’s wrong here: Type III causes mixed hyperlipidemia (both TG and cholesterol), not isolated massive TG with milky plasma.

What you’d expect instead:

• Cause: defective ApoE → impaired clearance of chylomicron remnants and IDL
• Labs: ↑ cholesterol and ↑ TG (both elevated)
• Clinical:
  • Palmar xanthomas (xanthoma striatum palmare) — very testable
  • Tuberous xanthomas
  • Premature atherosclerosis and peripheral vascular disease

Step tip: Palmar xanthomas are Type III until proven otherwise.

---

D. Increased hepatic VLDL production due to insulin resistance → Hypertriglyceridemia (often Type IV phenotype)

Why it’s wrong here: Insulin resistance elevates VLDL, but the vignette points to chylomicrons (milky plasma after refrigeration + eruptive xanthomas + childhood onset + severe pancreatitis).

What you’d expect instead:

• Typical patient: adult with obesity, metabolic syndrome, type 2 diabetes
• Labs: ↑ TG due to ↑ VLDL (not prominent chylomicrons unless extremely high TG)
• Clinical:
  • Pancreatitis can happen if TG becomes very high, but classic “milky plasma after refrigeration” is more Type I
• Mechanism: insulin resistance → ↑ FFA flux to liver → ↑ TG synthesis → ↑ VLDL secretion

Step tip: VLDL = endogenous TG (liver-made); chylomicrons = exogenous TG (diet).

---

E. Defective ABCA1 transporter → Tangier disease

Why it’s wrong here: Tangier disease is an HDL problem, not a chylomicron/TG clearance problem.

What you’d expect instead:

• Cause: defective ABCA1 → impaired cholesterol efflux to ApoA-I → very low HDL
• Clinical:
  • Orange tonsils
  • Peripheral neuropathy
  • Hepatosplenomegaly
• Labs: ↓ HDL, sometimes mild ↑ TG; not classically severe pancreatitis from chylomicronemia

Step tip: Orange tonsils = Tangier = ABCA1 = HDL efflux defect.

---

Rapid-Fire USMLE Table: Familial Dyslipidemias You Must Know

---

Exam-Ready Takeaways (What the test wants)

• Pancreatitis + eruptive xanthomas + milky plasma → Type I hyperchylomicronemia (LPL or ApoC-II deficiency).
• Tendon xanthomas + early CAD → LDL receptor/ApoB-100 (Type IIa).
• Palmar xanthomas + mixed lipids → ApoE mutation (Type III).
• Orange tonsils + low HDL → Tangier (ABCA1).

---

One more “Answer Choice” mindset trick

When you see lipids, ask two questions:

1. Which particle is elevated? (Chylomicron vs VLDL vs LDL vs remnants)
2. What complication dominates?
   • Pancreatitis → usually TG/chylomicrons/VLDL
   • Atherosclerosis/MI → usually LDL/remnants

That’s how you turn a memorization-heavy topic into a fast pattern-recognition win.